https://www.roche.com/de/products/products-list~type=diseases.htm

Indicaton

https://www.roche.com/de/products/products-list~type=diseases.htm

Therapeutic indications

Type of product

Table

Phase

Marketed
Available in

global

You may also be interested in

TOP-N53, TOP-V122, TOP-M119 and TOP-N44

TOPADUR has discovered and developed new dual-acting drugs that target the cGMP-Enzyme Regulation System to stimulate microcirculation, enable tissue regeneration, and avoid local oxygen deficiency. Based on our key invention we have developed an attractive portfolio of drug candidates to treat aging-related diseases as chronic wounds, glaucoma, colorectal cancer, hair loss and skin aging.

Phase I started

ScaiVision® CTCL IVD assay

It is an IVD for early detection of CTCL that will facilitate early detection of CTCL.

Proclarix

Proclarix® is CE marked, intended for in vitro diagnostic use and indicated for prostate cancer diagnosis in patients with normal digital rectal exam (DRE), enlarged prostate volume and elevated levels of PSA at 2-10 ng/ml.